Johnson & Johnson made a tough call recently. They stopped a mid-stage trial for a new eczema drug. The drug, JNJ-5939, was supposed to help people with moderate to severe eczema. But it didn't work as well as hoped. The trial showed that the drug was safe to use. People didn't have bad reactions t
Abigail Spanberger is about to make history in Virginia. She's the first woman and the first ex-CIA agent to become governor there. Her journey from intelligence work to politics is quite the story. Before politics, Spanberger spent years gathering secrets for the CIA. That's a far cry from her cur
Johnson Matthey, a big name in the chemical industry, has some big changes happening at the top. Richard Pike, who was the finance chief, is now the new Chief Operating Officer. This means he will be in charge of making sure the company runs smoothly every day. At the same time, Alastair Judge, who
